Literature DB >> 7536682

An improved panning technique for the selection of CD34+ human bone marrow hematopoietic cells with high recovery of early progenitors.

A A Cardoso1, S M Watt, P Batard, M L Li, A Hatzfeld, H Genevier, J Hatzfeld.   

Abstract

The human hematopoietic pluripotent repopulating "stem cell" is thought to be present within a minor subpopulation of CD34+ cells. This has not been definitively shown, although the more primitive CD34+ cell subset contains precursors for all lymphoid and nonlymphoid cell lineages. When purifying CD34+ cells, it is important to recover these early progenitors, which are more strongly immunoadsorbent to the separation devices. Using a commercialized panning system (AIS CELLector flasks), we observed that a high degree of purity requires a thorough washing procedure so that cells not binding or weakly binding to CD34 antibodies are removed. High recoveries can be obtained if the adherent cells are then efficiently detached by a 2-hour incubation in culture medium without added cytokines. In this way, we can routinely obtain 93.5 +/- 3.4% purity of CD34+ cells with a 74% yield of the multipotent colony-forming units (CFU-GEMM). Complete recovery of the putative "stem cell," or at least the early progenitor cell compartment (CD34+ CD38low/- CD34+ Thy-1+ cells), is also obtained. More than 30% of these cells can generate day-14 colonies in vitro. Comparable results were obtained when the separation was scaled up for clinical application using appropriate large-scale devices. The various incubation times of the procedure can be easily adjusted to the work schedule. This renders the procedure easy to handle, efficient, safe, and, because the cells can be observed under light microscopy, easy to control.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7536682

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  4 in total

1.  DNA-encoded antibody libraries: a unified platform for multiplexed cell sorting and detection of genes and proteins.

Authors:  Ryan C Bailey; Gabriel A Kwong; Caius G Radu; Owen N Witte; James R Heath
Journal:  J Am Chem Soc       Date:  2007-01-30       Impact factor: 15.419

Review 2.  Nanotechnology and cancer.

Authors:  James R Heath; Mark E Davis
Journal:  Annu Rev Med       Date:  2008       Impact factor: 13.739

Review 3.  How do I perform hematopoietic progenitor cell selection?

Authors:  Scott T Avecilla; Cheryl Goss; Sharon Bleau; Jo-Ann Tonon; Richard C Meagher
Journal:  Transfusion       Date:  2016-02-25       Impact factor: 3.157

4.  Targeted transduction of CD34+ hematopoietic progenitor cells in nonpurified human mobilized peripheral blood mononuclear cells.

Authors:  Min Liang; Nonia Pariente; Kouki Morizono; Irvin S Y Chen
Journal:  J Gene Med       Date:  2009-03       Impact factor: 4.565

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.